PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2017American Journal of Psychiatry381 citationsOpen Access

A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality

View Full Paper
SAScott T. AaronsonPSPeter SearsFRFrancis Ruvuna

Structured PICO

Does adjunctive Vagus Nerve Stimulation improve response, remission, and suicidality in patients with treatment-resistant depression compared to treatment as usual?

P
Population
Patients with treatment-resistant depression (severely ill patient population)
I
Intervention
Adjunctive Vagus Nerve Stimulation (VNS)
C
Comparator
Treatment as usual
O
Outcome
Efficacy outcomes including response, remission, and suicidality

In a 5-year observational registry, adjunctive vagus nerve stimulation provided enhanced antidepressant effects compared to treatment as usual for treatment-resistant depression.

Abstract

This registry represents the longest and largest naturalistic study of efficacy outcomes in treatment-resistant depression, and it provides additional evidence that adjunctive VNS has enhanced antidepressant effects compared with treatment as usual in this severely ill patient population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aaronson et al. (2017) studied this question.

synapsesocial.com/papers/69d0109164f28e43be79d588https://doi.org/10.1176/appi.ajp.2017.16010034
Ask AI
Helpful
Bookmark
Share
View Full Paper